PE27.01 Association between Basal Metabolic Index and vaccine-induced HIV-1 adaptive immunityE-posterTherapeutic vaccines, viral reservoirs and eradication/remission
PE27.02 The influence of HIV-1 subtype C LTR genotype on latency potentialE-posterTherapeutic vaccines, viral reservoirs and eradication/remission
PE27.03 Impact of baseline variables on time to viral rebound after treatment interruption in acutely treated HIV-1 infected participantsE-posterTherapeutic vaccines, viral reservoirs and eradication/remission
PU28.01 Findings from an HIV risk behavior assessment among penal and probation population in Ukraine  Publication OnlyTherapeutic vaccines, viral reservoirs and eradication/remission
OA02.05LB Risk factors for HIV transmission in heterosexual men, men who have sex with men, and transgender women participating in the HVTN 702 'Uhambo' and HVTN 503/503-S 'Phambili' HIV vaccine trialsOral Abstract SessionTransmission of HIV
OA22.01 R5 tropic HIV-1 is preferentially translocated of across genital mucosa while X4 tropic HIV-1 is selectively sequestered in genital epithelial cells and activates type I IFN signalingOral Abstract SessionTransmission of HIV
PE28.01 An analysis of gender-based violence and HIV risk among adolescents and youth across 10 countriesE-posterTransmission of HIV
PE28.02 Variable HIV seroincidence rates in a cohort of high-risk men who have sex with men (MSM) and transgender women (TGW) in ChinaE-posterTransmission of HIV
PE28.03 Site-level prevalence of gonorrhea and chlamydia is correlated with site-level HIV incidence in African women seeking contraceptionE-posterTransmission of HIV
PE28.04 Circulating South African transmitted/founder HIV-1 subtype C uses CCR5 and not CXCR4 or CCR3 for cell entryE-posterTransmission of HIV
seek-warrow-warrow-eseek-e421 - 430 of 444 items